.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Johnson and Johnson
Mallinckrodt
Farmers Insurance
UBS
Express Scripts
Cipla
Boehringer Ingelheim
Argus Health
Queensland Health

Generated: June 23, 2017

DrugPatentWatch Database Preview

PHENTERMINE RESIN 30 Drug Profile

« Back to Dashboard

What is the patent landscape for Phentermine Resin 30, and when can generic versions of Phentermine Resin 30 launch?

Phentermine Resin 30 is a drug marketed by Quantum Pharmics and is included in one NDA.

The generic ingredient in PHENTERMINE RESIN 30 is phentermine resin complex. There are seventeen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the phentermine resin complex profile page.

Summary for Tradename: PHENTERMINE RESIN 30

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list19
Clinical Trials: see list64
Patent Applications: see list4,496
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PHENTERMINE RESIN 30 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics
PHENTERMINE RESIN 30
phentermine resin complex
CAPSULE, EXTENDED RELEASE;ORAL089120-001Feb 4, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
QuintilesIMS
Boehringer Ingelheim
Federal Trade Commission
US Department of Justice
Cantor Fitzgerald
Fish and Richardson
Chubb
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot